Toxic Tetrahydrocannabinol (THC) Dose in Pediatric Cannabis Edible Ingestions

Lesley C Pepin1, Mark W Simon1, Shireen Banerji1

  • 1Rocky Mountain Poison & Drug Safety, Denver Health and Hospital Authority, Denver, Colorado.

Pediatrics
|August 28, 2023
PubMed

Insights

Edible cannabis toxicity in children under 6 is linked to tetrahydrocannabinol (THC) dose. A dose of 1.7 mg/kg THC predicts severe and prolonged toxicity, guiding medical care.

Area of Science:

  • Pediatric Toxicology
  • Cannabis Pharmacology
  • Public Health

Background:

  • Edible cannabis products pose risks to children, with toxicity varying by tetrahydrocannabinol (THC) content.
  • Understanding the dose-response relationship is crucial for managing pediatric ingestions.

Purpose of the Study:

  • To characterize cannabis toxicity in relation to THC dose in young children (<6 years) who ingested edible cannabis products.
  • To identify a potential THC dosage threshold predicting severe or prolonged toxicity.

Main Methods:

  • Retrospective review of pediatric patients (<6 years) with known edible cannabis THC ingestion doses.
  • Toxicity classified as severe (cardiovascular, respiratory, neurologic effects) or prolonged (>6 hours).
  • Multivariable logistic regression and ROC curve analysis to determine THC dose as a predictor.

Main Results:

  • Eighty patients included; median age 2.9 years, median THC ingestion 2.1 mg/kg.
  • Severe and prolonged toxicity observed in 46% and 74% of cases, respectively.
  • THC dose significantly predicted severe (aOR 2.9) and prolonged toxicity (aOR 3.2); ≥1.7 mg/kg THC predicted severe (97.3% sensitivity) and prolonged toxicity (75.4% sensitivity).

Conclusions:

  • Tetrahydrocannabinol (THC) dose in edible cannabis directly correlates with toxicity severity in children under 6.
  • A THC ingestion threshold of 1.7 mg/kg may inform clinical management and regulatory measures for pediatric cannabis exposure.
Abstract

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
311
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
230
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
851
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K